“…A select panel of genes was evaluated using the following Quantitect primers from Qiagen Inc. (Germantown, MD, USA): b-actin, Actb as the reference gene (catalog# QT00193473), interleukin-1b, Il1b (Qiagen catalog# QT00181657), the tumor necrosis factor, Tnf (Qiagen catalog# QT00178717), chemokine monocyte chemotactic protein (Mcp1/ Ccl2) [forward:5'-ATGAGTCGGCTGGAGAACTA-3', reverse: 5'ACTTCTGGACCCATTCCTTATTG-3'], Tgfb1 (Qiagen catalog# QT00187796), endoglin, Eng [forward: 5'-GCGTCCTT GTTCCAAACATTC-3', reverse 5'-ACAGCAAGAAGAGG CAAGAG-3'], e-Selectin (Sele) [forward:5'-GTATCCAT CCATCCCACAGAAG-3', reverse: 5'-CAGTTGTGTCCAC TCGATAGTT-3'], Icam-1, Icam1 [forward: 5'-GTATCCATCCA TCCCACAGAA-3', reverse: 5'-CAGTTGTGTCCACTCGAT AGTT-3', matrix metalloproteinase 2, Mmp2 [forward: 5'-TGGACTGGAGAAGGACAA-3', reverse: 5'-CTGCTGTATT CCCGACCATTA-3'], matrix metalloproteinase 9, Mmp9 [forward: 5'-CCCAACCTTTACCAGCTACTC-3', reverse: 5'-GTCAGAACCGACCCTACAAAG-3"], and the tissue inhibitor of metalloproteinase-1, Timp1[forward:5'-TGGCATCC TCTTGTTGCTATC-3', reverse: 5'-CCTTATAACCAGGT CCGAGTTG-3']. Real-time qPCR was performed with the Light Cycler ® 96 real-time PCR System (Roche Applied Science, Indianapolis, IN, USA) as previously described (Tavarna et al, 2022).…”